Paediatric Inherited Retinal Diseases: Early Recognition, Vision Impairment, and Emerging Therapies

Paediatric Inherited Retinal Diseases: Early Recognition, Vision Impairment, and Emerging Therapies

Available from: 1/10/2026 (AEST)

Where to publish: www.mieducation.com

Provider: Mivision

Contact: Nikki Byrne, [E] nikki@mivision.com.au, [P] 02 8336 8616

Activity Outline

For children and families, the consequences of inherited retinal diseases (IRDs) extend beyond vision, affecting education, mobility, social development, mental health, and family wellbeing. As new diagnostic technologies, genetic testing pathways, and emerging treatments become increasingly accessible, care for children with IRDs is changing rapidly. It is now more important than ever that eye care professionals accurately identify children with these conditions at an early stage, so that they may benefit from these new technologies. Early identification and definitive diagnosis through genetic testing also allows children and their families to have a clearer idea of the likely prognosis, allowing them to make the best choices for the lives ahead.

Professor Lauren Ayton AM reviews the clinical presentation of paediatric IRDs, the broader impacts of childhood vision impairment, and the evolving therapeutic landscape.

Learning Objectives

• Have an understanding of the more common forms of inherited retinal disease (IRD) that affect children,
• Be able to explain, at a high level, the types of emerging therapies being developed for IRDs,
• Understand the developmental, emotional, and social impacts of paediatric low vision from IRDs.

Max CPD hours awarded: 1

Session Information